Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.60
Bid: 7.50
Ask: 7.70
Change: -0.26 (-3.31%)
Spread: 0.20 (2.667%)
Open: 7.75
High: 7.60
Low: 7.60
Prev. Close: 7.86
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Apr 2013 12:34

RNS Number : 3621C
Port Erin Biopharma Investments Ltd
15 April 2013
 



Port Erin Biopharma Investments Limited

("Port Erin" or "the Company")

Changes to the Group's Board

The Board of Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, announces that Nicholas Woolard has informed the Board of his decision to stand down as a Non-Executive Director of the Company with immediate effect in order to allow him to focus on other business interests. Nicholas joined the Board in May 2011 prior to the Company's listing in September 2011, and has served on its Audit and Remuneration committees since that date.

The Board further announces the appointment of Alexander Anderson Stuart Whamond as a Non-Executive Director of the Company with immediate effect. Anderson, aged 52, has over 25 years' experience in the banking and financial sector. He began his career in 1983 at White Weld Securities (part of the CSFB group) before joining Salomon Brothers International in London in 1986 and then Morgan Stanley International in 1989 where he was a principal in charge of convertible bond trading. He joined Peregrine Securities International (UK) Limited in 1993, relocating to Hong Kong in 1996 to run the equity trading businesses of Peregrine Investment Holdings Limited and becoming a director of the executive committee of the Peregrine group in 1997. In 1998, Anderson joined the Regent Pacific Group, a Hong Kong listed international emerging markets investments group, as head of corporate investments and relocated to the Isle of Man. He joined the Charlemagne Group in 2002 and was a director of AIM quoted Charlemagne Capital Limited until March 2009. He remains a non-executive director of Charlemagne Capital (IOM) Limited and is also a director of a number of listed and non-listed investment companies.

Anderson Whamond will chair both the Audit and Remuneration committees.

Jim Mellon, Chairman, commented: "Nick has made a very significant contribution to Port Erin. I would like to thank Nick on behalf of the Board for his advice and support and to wish him well for the future. I also have great pleasure in welcoming Anderson to the board, bringing as he does a wealth of experience in the investment arena."

Anderson Whamond's Directorships:-

Current Directorships

 

Atherton Electrontics Group Limited

Charlemagne Bric Plus Real Estate Company Ltd

Charlemagne Bric Property Plus Company Plc

Charlemagne Capital (IOM) Limited

Charlemagne Capital (Services) Limited

Charlemagne New Frontiers Fund

Cherrywood Consulting Limited

European Convergence Development Company Ltd

European Convergence Property Company plc

Holmeglen Limited

Interman Limited

Magna Umbrella Fund Plc

MHA Lighting Limited

OCCO Eastern European Fund

Rothesay Limited

 

Previous Directorships

 

Appleyard Investments Limited

Asian Debt Fund

Asian Fortune Enterprises Limited

Asian Opportunities Fund 1998 - I

Bald Eagle Asian Equities (non US Feeder) Fund

Bald Eagle Asian Equities Fund

Balkan Holdings (Cyprus) Limited

Burnbrae Limited

Charlemagne Capital (Barbados) Limited

Charlemagne Capital (Advisory) Limited

Charlemagne Capital (Investments) Limited

Charlemagne Capital (Caymen) Limited

Charlemagne Capital (Property) Limited

Charlemagne Capital (Investments) Limited

Charlemagne Capital Russia Fund

Charlemagne Capital Limited

Charlemagne CIS Fund Limited

Charlemagne CIS Fund (Labuan) Limited

Charlemagne Finance (Cyprus) Limited

Charlemagne Emerging Markets Fund Plc

Daeyu Regent Securities Limited

Clefex.com (IOM) Limited

EEPF (Cyprus) Limited

Diamond River International Limited

Gold Victory Holdings Limited

EIH Plc

Homeport (Cayman) Limited

Hermes Softlab d.d.

Interman Services Limited

Interman Europe plc

International Fund Arbitrage

Interman UK Limited

Ironwood Enterprises LLC

Ireton Enterprises Limited

JEM Limited

Ironwood Partnership Limited

Navrona Investments Limited

Lattice Limited

Naya Bharat Property Company Plc

Naya Bharat Property Company (Mauritius) Ltd

Novy Neft Limited

Novy Neft II Limited

Oasis Group Limited

Nowe Finanse Limited

OCCO Global Emerging Markets Fund

OCCO Asia Fund

OCCO Latin America Fund Plc

OCCO Latin America Fund

Peregrine Securities (UK) Limited

Peregrine Brokerage Limited

Port Antonio Limited

Port Antonio Developments (St. Lucia) Limited

Quayle Munro Infrastructure Company Plc

Portland Investment Company Limited

Regent European Securities (Cayman) Limited

Regent Fund Management Limited

Regent Pacific Corporate Advisory Limited

Regent Magna Europa (Cyprus) Limited

Regent Pacific Fund

Regent Pacific Energy Limited

Regent Pacific Private Equity Limited

Regent Pacific Group Limited

RPG(L) Limited

Regent Russian Bond Fund

Sleepwell Hotels (UK) Limited

Sidebottom Holdings Limited

South Asia Fund

Sleepwell Hotels Limited

Spanish Off-Plan Properties Plc

Southwise Trading Limited

SWB Investments Limited

SWA Holdings Limited

TBF(Cyprus) Limited

SWR Investments Limited

Turtle Crawl Hill Limited

Techpacific.com Limited

Ukraine Investment Fund

UAR Investments Limited

Undervalued Assets Fund - Series V Plc

Undervalued Assets Fund - Series One

Undervalued Assets Thailand Fund

Undervalued Assets Property Fund - Series Two

Undervalued Opportunities Company Limited

Undervalued Opportunities (Master) Company Ltd

WTIC Limited

Walker Telecommunications Limited

 

Ends

For further information:

For further information, please contact:

Port Erin Biopharma Investments Ltd

Libertas Capital Corporate Finance Limited

Peterhouse Capital Limited

The Company

Nomad

Broker

 

 

 

Denham Eke

+44 162 463 9396

Sandy Jamieson

+44 207 569 9650

Jon Levinson

+44 207 562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMDMKFGFZM
Date   Source Headline
9th Dec 20193:00 pmRNSEquity Fundraise Closes at £7.7 million
6th Dec 20197:00 amRNSFinal Results
4th Dec 20197:00 amRNSUpdate on Placing and Final Results
11th Nov 20197:00 amRNSProposed Fundraise
29th Oct 20197:00 amRNSInvestment in Shiok Meats Pte. Ltd.
22nd Oct 20192:00 pmRNSCompany Newsletter
17th Oct 20197:00 amRNSInvestment in VitroLabs Inc
15th Oct 20197:00 amRNSInvestment in Rebellyous Foods
8th Oct 20197:00 amRNSNet Asset Value(s)
23rd Sep 20191:00 pmRNSAIM Rule 17 Notification
12th Sep 20197:00 amRNSInvestee Company Update
9th Sep 201911:55 amRNSHolding(s) in Company
5th Sep 20197:00 amRNSSeed Investment in Bond Pets LLC
29th Aug 20197:00 amRNSAgronomics Participates in BlueNalu Fund Raise
28th Aug 20199:42 amRNSNew website launched
27th Aug 20191:21 pmRNSInvestee company Update: Blue Nalu, Inc
12th Aug 201912:51 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSNet Asset Value(s)
29th Jul 20197:00 amRNSInvestment in Simply Foods, Inc. (New Age Meats)
5th Jul 20194:40 pmRNSSecond Price Monitoring Extn
5th Jul 20194:35 pmRNSPrice Monitoring Extension
3rd Jul 201912:58 pmRNSResult of Meeting
17th Jun 20192:05 pmRNSSecond Price Monitoring Extn
17th Jun 20192:00 pmRNSPrice Monitoring Extension
17th Jun 201911:00 amRNSPrice Monitoring Extension
13th Jun 20197:00 amRNSEquity Fundraise Closes at £4.5 million
10th Jun 20197:00 amRNSProposed Equity Fundraise
31st May 20199:30 amRNSBoard Appointments
16th Apr 20191:01 pmRNSResult of Meeting
10th Apr 20197:00 amRNSNet Asset Value
29th Mar 20197:00 amRNSCircular and Notice of General Meeting
29th Mar 20197:00 amRNSHalf-year Report
7th Feb 20197:00 amRNSNet Asset Value(s)
28th Dec 20182:20 pmRNSFinal Results
24th Oct 20187:00 amRNSNet Asset Value(s)
16th Aug 20187:00 amRNSInvestment in Blue Nalu, Inc.
18th Jul 20187:00 amRNSNet Asset Value(s)
28th Jun 20187:00 amRNSInvestee Company Update: Summit Therapeutics plc
23rd Apr 20187:00 amRNSNet Asset Value(s)
27th Mar 20189:30 amRNSHalf-year Report
9th Feb 201812:31 pmRNSResult of AGM
8th Feb 20187:00 amRNSChange of Adviser
22nd Jan 20187:00 amRNSNet Asset Value(s)
28th Dec 20174:49 pmRNSFinal Results
19th Oct 20177:00 amRNSNet Asset Value(s)
20th Jul 201711:00 amRNSNAV & Investment in AgeX Therapeutics Inc.
25th Apr 20177:00 amRNSRedemption of Interest in Magna Biopharma Fund
12th Apr 20177:00 amRNSNet Asset Value(s)
29th Mar 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.